| Assay ID | Title | Year | Journal | Article |
|---|
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1223055 | Effect on Ugt1a7c gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223036 | Induction of Cyp4f13 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223024 | Effect on Ugt1a6b gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222991 | Induction of Cyp2c9 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223058 | Effect on Ugt1a9 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223043 | Induction of Cyp4f15 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222993 | Induction of Cyp2c55 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223066 | Effect on Ugt2b34 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223063 | Effect on Ugt2b5 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222996 | Induction of Cyp2c39 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223027 | Drug metabolism in male PXR null mouse assessed as urinary alpha-carboxyethylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223057 | Effect on Ugt1a9 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222997 | Drug metabolism in male PXR-humanized mouse assessed as urinary alpha-carboxyethylhydroxychroman glycine level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223040 | Induction of Cyp4f14 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223062 | Effect on Ugt2b5 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222988 | Reduction in Cyp4a10 gene expression in PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223053 | Effect on Ugt1a7c gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223061 | Effect on Ugt1a10 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223049 | Induction of Cyp4f18 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222990 | Induction of Cyp2c9 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223041 | Induction of Cyp4f15 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223022 | Effect on Ugt1a6b gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223037 | Induction of Cyp4f13 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222999 | Drug metabolism in male PXR-humanized mouse assessed as urinary alpha-carboxyethylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID308944 | Vasodilation of noradrenaline-induced contraction of Wistar Kyoto rat thoracic aorta at 20 uM | 2007 | Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
| Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization. |
| AID1223017 | Effect on Ugt1a1 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223048 | Induction of Cyp4f18 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223064 | Effect on Ugt2b5 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223025 | Drug metabolism in male wild type mouse assessed as urinary alpha-carboxymethylbutylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223051 | Induction of Cyp1a2 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223034 | Induction of Cyp3a11 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223056 | Effect on Ugt1a9 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222989 | Induction of Cyp2c9 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223059 | Effect on Ugt1a10 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223047 | Induction of Cyp4f18 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223003 | Induction of Cyp2c39 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223046 | Induction of Cyp4f16 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223035 | Induction of Cyp4f13 gene expression in male wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method relative to untreated control | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222998 | Drug metabolism in male wild type mouse assessed as urinary alpha-carboxyethylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223044 | Induction of Cyp4f16 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223060 | Effect on Ugt1a10 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223026 | Drug metabolism in male PXR null mouse assessed as urinary alpha-carboxyethylhydroxychroman glycine level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223045 | Induction of Cyp4f16 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223020 | Effect on Ugt1a6a gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223023 | Effect on Ugt1a6b gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223065 | Effect on Ugt2b34 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223052 | Induction of Cyp2e1 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222994 | Induction of Cyp2c37 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223038 | Induction of Cyp4f14 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223039 | Induction of Cyp4f14 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223021 | Effect on Ugt1a6a gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223028 | Drug metabolism in male PXR null mouse assessed as urinary alpha-carboxymethylbutylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223019 | Effect on Ugt1a6a gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223033 | Induction of Cyp3a11 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223016 | Effect on Ugt1a1 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID977602 | Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6
| Structure-based identification of OATP1B1/3 inhibitors. |
| AID1223001 | Drug metabolism in male wild type mouse assessed as urinary alpha-carboxyethylhydroxychroman glycine level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223032 | Induction of Cyp3a11 gene expression in male wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223018 | Effect on Ugt1a1 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222992 | Induction of Cyp2c55 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222987 | Induction of Cyp2b10 gene expression in wild type mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223067 | Effect on Ugt2b34 gene expression in male PXR-humanized mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1222995 | Induction of Cyp2c44 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223042 | Induction of Cyp4f15 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223054 | Effect on Ugt1a7c gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223002 | Induction of Cyp2c39 gene expression in male PXR null mouse liver at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by qPCR method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID1223000 | Drug metabolism in male PXR-humanized mouse assessed as urinary alpha-carboxymethylbutylhydroxychroman glucuronide level at 500 mg/kg for 7 to 14 days dosed through vitamin E-deficient base diet by UPLC-ESI-QTOFMS method based metabolomics analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
| Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6
| A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1064556 | Drug degradation in mouse N18TG2 cells assessed as alpha-TOH formation at 10 nmol after 24 hrs by HPLC analysis | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID631285 | Protection against H2O2-induced cell damage in NHEK assessed as inhibition of PGE2 production at 0.5 to 2 uM after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID1064575 | Inhibition of bovine mitochondrial electron transport protein complex 2 succinate:DCPIP oxidoreductase activity by spectrophotometry | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID631276 | Protection against IL1-beta-induced cell damage in NHEK assessed as inhibition of PGE2 production at 2 uM pretreated for 24 hrs before IL1-beta challenge measured after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID1064570 | Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH after 2 mins by ESR spectroscopy relative to control | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID631235 | Protection against H2O2-induced cell damage in NHEK assessed as inhibition of PGE2 production at 2 uM pretreated for 24 hrs before H2O2 challenge measured after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID1064574 | Inhibition of bovine mitochondrial electron transport protein complex 3 dUQH2:cytochrome c oxidoreductase activity by spectrophotometry | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID631278 | Protection against IL1-beta-induced cell damage in NHEK assessed as inhibition of PGE2 production at 0.1 uM pretreated for 24 hrs before IL1-beta challenge measured after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID1416210 | Inhibition of PTP1B (1 to 298 residues) (unknown origin) using DifMUP as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by fluorescence assay | 2017 | MedChemComm, Jun-01, Volume: 8, Issue:6
| PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B. |
| AID1064571 | Induction of superoxide radical generation in bovine NADH-respiring submitochondrial particles assessed as oxidation of CPH after 2 mins by ESR spectroscopy relative to control | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID631221 | Prodrug conversion in 3D restructured human skin model assessed as conversion of compound to dl-alpha-tocopherol at 2% after 4 hrs by HPLC analysis | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID631240 | Protection against t-BHP-induced cell damage in NHEK assessed as inhibition of PGE2 production at 2 uM pretreated for 24 hrs before t-BHP challenge measured after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID631277 | Protection against IL1-beta-induced cell damage in NHEK assessed as inhibition of PGE2 production at 0.5 uM pretreated for 24 hrs before IL1-beta challenge measured after 24 hrs by enzymatic immunoassay | 2011 | Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
| Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants. |
| AID1064560 | Induction of superoxide radical generation in mouse N18TG2 cells assessed as CMH oxidation at 200 uM after 2 hrs by ESR spectroscopy relative to control | 2014 | Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
| Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. |
| AID103204 | Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay | 1998 | Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
| Design and synthesis of analogs of vitamin E: antiproliferative activity against human breast adenocarcinoma cells. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11
| 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |